20250161289. Kat6 Targeti (Prelude Therapeutics Incorporated)
Appearance
KAT6 Targeting Compounds
Abstract: the present disclosure provides bifunctional compounds comprising a target protein binding moiety and a e3 ubiquitin ligase binding moiety, and associated methods of use.
Inventor(s): Chun Chen, Sarah Pawley, Andrew Buesking, Andrew Combs
CPC Classification: A61K31/4545 (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms ; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles ; soap compositions ))
Search for rejections for patent application number 20250161289